|
Ovarian cancer Articles
Ovarian cancer News : New IVDMIA for Ovarian Cancer Available Wed, 10 Mar 2010 06:53:33 GMT OVA1â¢, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc., the world's leading cancer diagnostics provider.Ovarian cancer News : Quest Diagnostics to offer new ovarian cancer test Mon, 08 Mar 2010 22:00:46 GMT Medical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer.Quest Diagnostics to Offer New Ovarian Cancer Test Mon, 08 Mar 2010 22:46:51 GMT Quest Diagnostics selling presurgical ovarian cancer test, cites improved treatment potential Cancer - Ovarian cancer - Quest Diagnostics - Health - Conditions and DiseasesQuest Diagnostics to offer new ovarian cancer test Mon, 08 Mar 2010 22:45:19 GMT Medical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer. The OVA1 test, which was approved by the Food and Drug Administration in September, will be sold... Quest Diagnostics - Cancer - Food Drug Administration - Health - Conditions and DiseasesOVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer Tue, 09 Mar 2010 13:06:00 GMT OVA1â¢, the first blood test cleared by the U.S. Food and Drug Administration for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc. , the world's leading cancer diagnostics provider.Nektar has positive data from ovarian cancer study Mon, 08 Mar 2010 15:47:40 GMT Nektar Therapeutics on Monday reported that early results from a trial of an experimental cancer drug suggest a slowing in the progression of ovarian cancer.Study says diet may have role in ovarian cancer survival rate Mon, 08 Mar 2010 23:30:34 GMT LOS ANGELES â Momâs admonishments to eat your fruits and vegetables should still be heeded, since a new study found that a diet high in fruits, vegetables and healthful grains may be associated with higher survival rates for those diagnosed with ovarian cancer.Researchers from the University of Illinois at Chicago examined data from a longitudinal study looking at the self-reported, pre ...Quest Diagnostics to offer new ovarian cancer test Mon, 08 Mar 2010 22:17:16 GMT Quest Diagnostics selling presurgical ovarian cancer test, cites improved treatment potentialPositive Phase 2 data from Nektar Therapeutics' NKTR-102 study in women with platinum-resistant ovarian cancer Mon, 08 Mar 2010 15:09:26 GMT Nektar Therapeutics today announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients were enrolled with platinum-resistant disease and were evaluable for the secondary endpoint of progression-free ...Diet may play part in ovarian cancer survival rates Mon, 08 Mar 2010 11:58:47 GMT LOS ANGELES--Mom's admonishments to eat your fruits and vegetables should still be heeded, since a new study found that a diet high in fruits, vegetables and healthful grains may be associated with higher ovarian cancer survival rates.Drinking tea 'cuts down ovarian cancer risk' Mon, 08 Mar 2010 09:33:00 GMT Having two cups of black tea or one cup of green tea a day can help cut down risk of developing ovarian cancer in women, says a study.Nektar announces positive phase 2 data from first stage of NKTR-102 study in women with platinum-resistant ovarian ... Wed, 10 Mar 2010 12:43:44 GMT Nektar Therapeutics announced preliminary progression-free survival data from the first stage of a two-stage phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer.Drinking tea 'cuts down ovarian cancer risk' Mon, 08 Mar 2010 08:14:55 GMT London, March 8 : Having two cups of black tea or one cup of green tea a day can help cut down risk of developing ovarian cancer in women, says a study.Women of Hope supports people affected by cancer Wed, 10 Mar 2010 04:08:09 GMT A group called Women of Hope is designed to support women through any type of cancer, whether it be breast cancer, cervical cancer or ovarian cancer.New test to detect ovarian cancer - women's 'silent killer' Sat, 06 Mar 2010 23:17:26 GMT Nearly 7,000 women are diagnosed with ovarian cancer each year in the United Kingdom but now a new screening test has been developed which should help in the early detection of the disease.Good Diet May Aid Ovarian Cancer Survival Fri, 05 Mar 2010 21:18:24 GMT Title: Good Diet May Aid Ovarian Cancer Survival Category: Health News Created: 3/5/2010 10:26:00 AM Last Editorial Review: 3/5/2010 10:26:12 AMRelay for Life : Changing the channel on cancer Wed, 10 Mar 2010 16:23:00 GMT MARCO ISLAND âThe American Cancer Society âs Marco Island Chapter will hold its signature community event, Relay for Life , on Saturday. Cancer survivors, caregivers, and the greater Marco community will gather as part of the worldâs largest movement to end the disease.Each year, more than 3 million people around the globe now participate in Relay for Life to celebrate survivors, raising money ...Pre-Diagnosis Diet Linked to Ovarian Cancer Survival Thu, 04 Mar 2010 21:03:28 GMT THURSDAY, March 4 (HealthDay News) -- Healthy eating habits lead to longer survival for ovarian cancer patients, U.S. researchers say.Reovirus May Be A Novel Approach To Prostate Cancer Treatment Wed, 10 Mar 2010 14:15:06 GMT Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research. The respiratory, enteric, orphan virus (commonly known as reovirus) is a non-attenuated, environmental virus that has shown oncolytic potential ...Relay for Life: Changing the channel on cancer Wed, 10 Mar 2010 16:38:29 GMT The American Cancer Societyâs Marco Island Chapter will hold its signature community event, Relay for Life, on Saturday. Cancer survivors, caregivers, and the greater Marco community will gather as part of the worldâs largest movement to end the disease.OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update4) Tue, 09 Mar 2010 21:56:05 GMT March 9 (Bloomberg) -- OSI Pharmaceuticals Inc .âs status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc.Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin(R) Wed, 10 Mar 2010 10:29:56 GMT Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin®. The Japanese patent award is another step forward in the development of one of our lead clinical drug candidates, Archexin ...Treating prostrate cancer with virus? Wed, 10 Mar 2010 07:15:03 GMT The new therapy, which seeks to identify cancer cells, to invade and destroy them, uses a reovirus, from a family of common viruses that cause mild, even undetectable, stomach and respiratory illnesses.Tumor-Melting Virus vs. Prostate Cancer Tue, 09 Mar 2010 20:02:09 GMT Reovirus is harmless to normal cells -- but it destroys many kinds of cancer cells. A new study in patients with prostate cancer takes the virus closer to being a new cancer treatment.Reovirus may help fight prostate cancer Wed, 10 Mar 2010 08:18:10 GMT Scientists in Canada are working on a new way to treat prostate cancer using a virus.Questioning The Benefits Of Elective Removal Of Ovaries During Hysterectomy: Evidence Suggests Procedure May Do More ... Wed, 10 Mar 2010 16:31:12 GMT Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55 percent of all US women having a hysterectomy, or approximately 300,000 times each year. An article in the March/April issue of the Journal of Minimally Invasive Gynecology suggests that this ...Researchers in Canada discover novel oncolytic viral therapy against prostate cancer Wed, 10 Mar 2010 06:07:43 GMT Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.Virus that 'kills off' prostate cancer cells: Volunteer patients injected with 'tame' bug Tue, 09 Mar 2010 23:47:16 GMT Scientists injected six volunteer patients with the 'tame' virus - and found it killed off cancer cells while sparing normal tissue.Reovirus may help fight prostate cancer Wed, 10 Mar 2010 06:42:20 GMT Washington, March 10 : Scientists in Canada are working on a new way to treat prostate cancer using a virus.Reovirus may be a novel approach to prostate cancer treatment Tue, 09 Mar 2010 19:23:19 GMT Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to a new study.Tunes For Teal: An Ovarian Cancer Fundraiser Fri, 05 Mar 2010 14:19:15 GMT Tunes for Teal a unique event that's using music as a fundraiser for ovarian cancer research and awareness.Good Diet May Aid Ovarian Cancer Survival Thu, 04 Mar 2010 22:18:45 GMT Women who eat a healthy diet in the years before their ovarian cancer diagnosis may live longer than those who don't, according to a new study.Virus eyed as new treatment for prostate cancer Tue, 09 Mar 2010 20:31:47 GMT Canadian researchers are working on a fascinating new way to treat prostate cancer using viruses. And while it's still early days, they say their research opens the door to more effective cancer therapies.OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update4) Tue, 09 Mar 2010 08:18:06 GMT OSI Pharmaceuticals Inc.âs status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc. must pay to acquire it.'Tame' virus could prove prostate cancer weapon Tue, 09 Mar 2010 18:18:53 GMT A ''tame'' virus could prove to be a future weapon against prostate cancer, early research suggests.New study questions benefits of elective removal of ovaries during hysterectomy Wed, 10 Mar 2010 03:24:18 GMT Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55% of all U.S. women having a hysterectomy, or approximately 300,000 times each year. A new article suggests that this procedure may do more harm than good.Reovirus May be a Novel Approach to Prostate Cancer Treatment Tue, 09 Mar 2010 18:16:01 GMT 1)Therapeutic activity demonstrated in vitro and in vivo; 2) Virus' effect is selective for prostate cancer; not normal tissue; 3) Safety and efficacy shown in early-stage prostate cancer.Study Questions Benefits Of Elective Removal Of Ovaries During Hysterectomy Tue, 09 Mar 2010 23:16:28 GMT Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55% of all U.S. women having a hysterectomy, or approximately 300,000 times each year.New Cancer Fighting Test Hits Doctors' Offices Wed, 10 Mar 2010 21:18:12 GMT A much anticipated weapon against one of the deadliest cancers for women is now available.New study questions benefits of elective removal of ovaries during hysterectomy Tue, 09 Mar 2010 21:34:58 GMT ( Elsevier Health Sciences ) Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55 percent of all US women having a hysterectomy, or approximately 300,000 times each year. An article in the March/April issue of the Journal of Minimally Invasive ...Cellectar completes patient enrollment in Phase 1 cancer trial Tue, 09 Mar 2010 15:48:23 GMT Radiopharmaceuticals company Cellectar Inc. has enrolled the last of eight patients in a Phase 1 trial of its cancer-treating drug candidate. The trial is designed to measure drug safety and dosimetry of Cellectarâs lead compound, called CLR1404. Dosimetry refers to the measurement of doses, which also allows investigators to understand how a drug will affect non-tumor [...]Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin Tue, 09 Mar 2010 09:35:19 GMT Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, recently announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin.OSI Bid Likely to Rise as Astellas Seeks Cancer Sales Tue, 09 Mar 2010 03:37:57 GMT March 9 (Bloomberg) -- OSI Pharmaceuticals Inc.âs status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astell...Study Finds Delay In Referrals For Older Women With Ovarian Cancer Thu, 04 Mar 2010 11:33:35 GMT A study of electronic patient records, funded by the Wellcome Trust, suggests that older women with suspected ovarian cancer may be referred by their GPs for investigation later than younger women. Researchers at the Brighton and Sussex Medical School studied records from the General Practice Research Database (GPRD) and compared recorded diagnoses of ovarian cancer against rates in the UK ...Quest Launches OVA1, Pegs Market as 1 Million Women Annually Tue, 09 Mar 2010 14:50:12 GMT Quest and Vermillion have formally launched their OVA1 ovarian cancer test, the companies said today. The assay, cleared by the FDA last September, is designed to help physicians identify women in whom an ovarian mass is malignant, which would influence who performs the surgery to remove the mass.Inside Colonoscopy Screenings Wed, 10 Mar 2010 18:30:09 GMT Dr. Mark Pochapin Explains How Doctors Perform This Important Test for Colon CancerNektar Announces Positive Phase 2 Clinical Data From First Stage Of NKTR-102 Study In Women With Platinum-Resistant ... Tue, 09 Mar 2010 12:32:29 GMT Nektar Therapeutics (Nasdaq: NKTR) announced preliminary progression-free survival data from the first stage of a two-stage Phase 2 clinical study evaluating single-agent treatment with NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients were enrolled with platinum-resistant disease and were evaluable for the secondary endpoint of progression ...Older women with suspected ovarian cancer often not referred for investigation as quickly as younger women Thu, 04 Mar 2010 06:09:22 GMT Older women with suspected ovarian cancer are often not referred for investigation as quickly as younger women, new research suggests.Phase III GOG-212 clinical trial of CTI's OPAXIO for ovarian cancer: Enrollment to continue Thu, 04 Mar 2010 09:09:52 GMT Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO⢠used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial ... |
Infectious and parasitic diseases |
|
|
< Home > |
||